- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł576.4m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.50
7D
-1.6%
1Y
5.2%
Ryvu Therapeutics
Market Cap: zł350.5m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł14.62
7D
5.2%
1Y
-53.4%
Molecure
Market Cap: zł124.4m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.97
7D
9.7%
1Y
-0.2%
Poltreg
Market Cap: zł108.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.35
7D
-3.2%
1Y
-44.4%